Highlights
NASDAQ: TRIL       Trillium Therapeutic
Last Price Today's Change   Day's Range   Trading Volume
7.77   +0.99 (14.60%)  6.03 - 7.95  4,362,800

Overview

 
Avg Volume (4 weeks):2,796,426
4 Weeks Range:4.90 - 7.95
4 Weeks Price Volatility (%):
94.10%
52 Weeks Range:0.241 - 7.97
52 Weeks Price Volatility (%):
97.41%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Trillium Therapeutics Inc is a Canadian clinical stage immuno-oncology company which is engaged in developing therapies for the treatment of cancer. The lead program of the company is TTI-621 which is designed to act as a soluble decoy receptor, preventing CD47 from delivering its inhibitory signal. The company has proprietary medicinal chemistry platform, using fluorine chemistry which permits the creation of new chemical entities with pharmacological properties. The company operates through the single segment being Research and development of therapies for the treatment of cancer.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

5548  2619  509  162 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CETX 2.58+1.633 
 VISL 0.36+0.066 
 DGLY 1.97+0.85 
 GE 6.76+0.19 
 AESE 3.96+1.51 
 PFE 35.46-2.73 
 NIO 4.26+0.28 
 NCLH 17.29+1.63 
 F 5.87+0.16 
 HTZ 0.89-0.11 
Partners & Brokers